# Relmada Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/relmada-therapeutics

- Industry: Pharmaceuticals
- Headquarters: New York, US
- Website: www.relmada.com
- Total disclosed funding: $3M
- Latest round: Series A (Jul 24, 2012)
- Investors on record: 2

## About

Founded in 2004 and based in New York, US, Relmada Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company that develops orally-administered medications for chronic pain associated with depression, central nervous system, and ophthalmic disorders.

## Funding rounds

- Series A, Jul 24, 2012, $3M — Ben Franklin Technology Partners, BioAdvance

## Investors

- Ben Franklin Technology Partners (https://capitalatlas.ai/funds/ben-franklin-technology-partners) — Series A
- BioAdvance (https://capitalatlas.ai/funds/bioadvance) — Series A